Supplementary materials: Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients.pdf

Supplementary Figure 1. Flow diagram summarizing the number of patients with medication data available at each encounter across the two study populations. Supplemental Table 1. List of 65 medications collected in the PCI and allo-HCT populations with corresponding CPIC level of evidence and FDA evidence classification (sorted alphabetically). Supplementary Table 2. Summary of CYP2C19 Simulation Analysis Supplementary Table 3. Summary of CYP2D6 Simulation Analysis Supplementary Table 4. Summary of Simulation Analysis for additional genes